News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic
Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic. Evotec and Claris announce acceleration framework to support biotech companies with clinical trials -
COMMUNIQUÉ DE PRESSE
Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV
Evotec SE expands partnership with ABL to develop and manufacture broadly neutralising antibodies against HIV, funded by NIAID. The collaboration aims to supply clinical material for ongoing global trials
